Alzheimer's disease (AD) is the most common form of dementia in the elderly, and affects
millions of people worldwide. As the number of AD cases continues to increase in both …

Despite increasing evidence of major differences between rodent and human immune and
neurological function, relatively few biomedical studies are performed with human cells. This …

Defective brain hormonal signaling has been associated with Alzheimer's disease (AD), a
disorder characterized by synapse and memory failure. Irisin is an exercise-induced …

Alzheimer's disease (AD) is a devastating neurological disorder that still lacks an effective
treatment, and this has stimulated an intense pursuit of disease‐modifying therapeutics …

Alzheimer's disease (AD) and type 2 diabetes appear to share similar pathogenic
mechanisms. dsRNA-dependent protein kinase (PKR) underlies peripheral insulin …

Neuronal protein synthesis is essential for long-term memory consolidation, and its
dysregulation is implicated in various neurodegenerative disorders, including Alzheimer's …

Alzheimer's disease (AD) is a devastating neurodegenerative disorder and a major medical
problem. Here, we have investigated the impact of amyloid-β (Aβ) oligomers, AD-related …

Alzheimer's disease (AD) is a severe neurodegenerative disorder still in search of effective
methods of diagnosis. Altered levels of the NMDA receptor co-agonist, d-serine, have been …

Alzheimer9s disease (AD) is characterized by progressive cognitive decline, increasingly
attributed to neuronal dysfunction induced by amyloid-β oligomers (AβOs). Although the …

Abstract Background Mesenchymal stem cells (MSCs) have been explored as promising
tools for treatment of several neurological and neurodegenerative diseases. MSCs release …